Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;86(1):15-24.
doi: 10.1007/s00280-020-04086-0. Epub 2020 Jun 4.

Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate

Kathleen Dekeister  1   2 , Pierre-Adrien Bolze  3   4 , Michel Tod  5 , Rémi Tod  5 , Jérôme Massardier  3   6 , Jean-Pierre Lotz  7 , Touria Hajri  3 , Olivier Colomban  5 , Michael J Seckl  8 , Ray Osborne  9 , Gilles Freyer  10   5 , François Golfier  5   3   4 , Benoit You  10   5   3
Affiliations

Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate

Kathleen Dekeister et al. Cancer Chemother Pharmacol. 2020 Jul.

Abstract

Purpose: In a low-risk gestational trophoblastic neoplasia (GTN) treated with methotrexate (MTX), the modeled hCG (human chorionic gonadotropin) residual concentration (hCGres), calculated with NONMEM program® (NM) during the first 50 treatment days, is a predictor of MTX-resistance risk. This model was implemented with another algorithm on https://www.biomarker-kinetics.org/hCG . The objective was to confirm the validity of the website estimations with respect to NM.

Methods: The consistencies of modeled hCGres estimated by NM and by the website were assessed in a dataset of 60 fictive patients with simulated hCG profiles, as well as in an independent database of 531 actual patients. Moreover, the hCGres predictive values regarding MTX failure-risk were assessed.

Results: The values of hCGres obtained with both methods were highly consistent in the fictive patient and in the actual patient datasets: median relative prediction errors (RPE) were - 0.059 and 9.9 × 10-7, respectively. The ROC AUCs for predictions of MTX failure-risk were 0.90 (95% CI 0.87,0.93) with both NM and the website. The gradual association between increasing hCGres and the 2-year MTX failure-free survival was confirmed.

Conclusion: There is a high consistency of hCGres estimates obtained with the two methods. The website is meant to help clinicians in the interpretation of hCG decline curves of MTX-treated GTN patients. hCGres is now validated for more than 1690 patients in four independent datasets, and its recognition as an early predictor of MTX resistance for treatment adjustment and for the future studies should be considered.

Keywords: Algorithms; Chorionic gonadotropin; Drug resistance; Gestational trophoblastic disease; Neoplasm; Online systems.

PubMed Disclaimer

References

    1. FIGO Oncology Committee (2002) FIGO staging for gestational trophoblastic neoplasia 2000. FIGO oncology committee. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 77:285–287 - DOI
    1. Bagshawe KD, Dent J, Newlands ES et al (1989) The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 96:795–802 - DOI
    1. Chalouhi GE, Golfier F, Soignon P et al (2009) Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity. Am J Obstet Gynecol 200:643.e1–6. https://doi.org/10.1016/j.ajog.2009.03.011 - DOI
    1. Seckl MJ, Sebire NJ, Berkowitz RS (2010) Gestational trophoblastic disease. Lancet Lond Engl 376:717–729. https://doi.org/10.1016/S0140-6736(10)60280-2 - DOI
    1. You B, Pollet-Villard M, Fronton L et al (2010) Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias. Ann Oncol Off J Eur Soc Med Oncol 21:1643–1650. https://doi.org/10.1093/annonc/mdq033 - DOI

Publication types

LinkOut - more resources